P21 PeptideNeurotrophic PeptideSafety Rating 6/10
Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.
Price Comparison
Compare vendors · per 10mg
Overview
About P21 Peptide
Mechanism of action
Tetrapeptide derived from ciliary neurotrophic factor (CNTF); activates gp130 signaling; promotes BDNF expression and neurogenesis; enhances synaptic plasticity; reduces Alzheimer's tau pathology.
Safety profile
Very limited human data. Generally well-tolerated in animal studies. · BDNF mimetic; limited data but no proven harms; theoretical mechanism favorable
Storage
Stability & handling
🔔 Get notified when the price drops anywhere
No account required. We scan 30+ vendors daily — one email the moment any vendor drops P21 Peptide below your target.
Related pages
More on P21 Peptide
Stack & Compare
Frequently Researched Together
Research
Studies & key findings
- p21/CDKN1A is the primary effector of p53-driven cell cycle arrest and a central mediator of cellular senescence; it can function as both a classical tumor suppressor (arresting damaged cells) and, paradoxically, as a proto-oncogenic survival factor in established tumors, with its role determined by cellular context, subcellular localization, and interaction partners.
- A 2021 Science study found that p21-activated cells produce a bioactive secretome (PASP, including CXCL14) that recruits macrophages for immunosurveillance of stressed and precancerous cells — a tumor-suppressive mechanism; persistent p21 expression triggers M1 macrophage polarization and cytotoxic T-cell recruitment, placing stressed cells under immune clearance.
